Plain-English translation of NCT06730750 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is one of the first times this treatment has been tested in people.
This is an early-stage trial of , a new experimental cancer treatment being tested in people with advanced solid tumors. Researchers want to see if this medication works better when given by itself or combined with , a drug already used to treat certain cancers. The trial will enroll about 360 people and is designed to test safety, tolerability, and effectiveness.
Many advanced cancers stop responding to standard treatments or come back after initial therapy. This medication targets a specific protein found on certain cancer cells, offering a potentially new way to fight tumors that haven't responded to other options.
You likely qualify if…
You likely don't qualify if…
Participants will receive the new medication as an injection or infusion, either alone or combined with , at a medical center in a series of treatment cycles. You'll have regular visits for blood tests, imaging scans, and check-ups to monitor how the treatment is working and any side effects. The trial has different phases to first test safety and then effectiveness, so the exact schedule and duration will depend on which part of the trial you join and how well the treatment works for you.
AI-generated summary from trial data · Jul 5, 2026 · Not medical advice
United States
Australia